Introduction
============

Diabetes mellitus is a chronically progressive, metabolic disease that affects multiple organs over a period of time. In a diabetic patient, blood glucose levels are high as the body either fails to produce insulin or cells are not sensitive enough to insulin***.*** To ensure normal blood sugar levels, most diabetic patients have to take lifelong medications that affect the quality of life. [@ref-15] reported that the incidence of diabetes has increased phenomenally all over the world. It is frightening to contemplate that the prevalence of diabetes had increased by 30.6% from 2005 to 2015 ([@ref-6]). The onset of diabetes is associated with many factors, including other chronic diseases ([@ref-44]), social conditions ([@ref-45]), and even global warming ([@ref-5]). In summary, diabetes is a chronic disease of complex etiology and poses a threat to global health.

Based on pathogenesis, diabetes can be mainly classified into three types: gestational diabetes, type 1 diabetes (T1D), and type 2 diabetes (T2D). In general, T1D is known as insulin-dependent diabetes and often occurs in children and adolescents. In patients with T1D, beta cells of islets undergo cell-mediated autoimmune destruction. As a result, the pancreas of T1D patients cannot synthesize and secrete insulin on its own. Furthermore, T2D is known as non-insulin-dependent diabetes mellitus, which is the most common type of diabetes. Approximately 90% of diabetic patients are diagnosed with T2D. It often occurs in patients above the age of 35. In these patients, insulin secretion decreases either due to the lack of insulin receptors or impaired insulin receptors. Gestational diabetes is defined as a condition in which a normal woman develops diabetes during pregnancy. Gestational diabetes usually occurs in the middle or late stages of pregnancy. Some studies monitored women with gestational diabetes for six months after delivery. They found that 38 to 100% of these lactating mothers developed T2DM within six months of delivery ([@ref-22]). This suggests that there is an intrinsic link between gestational diabetes and T2D. In addition to these three types, there are some rare types of diabetes, including maturity onset diabetes of the young (MODY), maternally inherited diabetes and steroid diabetes. MODY and maternally inherited diabetes are primary and hereditary diseases. The genetic patterns of them are autosomal dominant and maternal inheritance, respectively. Steroid diabetes is a secondary metabolic disorder caused by excessive glucocorticoids in the body.

With the development of precision medicine, researchers can now pay more attention to patients with childhood-onset T2D. [@ref-46] noted that although T2D is common in people above the age of 35, the incidence of T2D has continued to rise in children. Both children and adolescents have physiological conditions that are different from those of adults; therefore, researchers must focus on the prevention, clinical diagnosis, and drug treatment of childhood-onset T2D. Researchers in Mexico have conducted several cross-sectional studies on children and adolescents in the area. The results indicate that T2D and metabolic syndrome-related traits were highly inherited in Mexican children and adolescents ([@ref-29]). [@ref-19] found that statins increased the risk of childhood-onset T2D without causing dyslipidemia. [@ref-27] found that the risk of developing T2D increased significantly in children and adolescents with mental disorders when they were exposed to atypical antipsychotics. [@ref-1] analyzed whether the published anti-hyperglycemic drugs were safe and effective for children and adolescents. These studies have partially revealed some links of T2D in children and adolescents. Nevertheless, scientists still do not know the molecular mechanism of childhood-onset T2D. Therefore, it is necessary to identify the genes and pathways related to the pathogenesis of childhood-onset T2D. Then, we can develop special measures for the prevention and treatment of childhood-onset T2D.

The microarray data ([GSE9006](GSE9006)) was used to compare the intrinsic characteristics of following three groups: healthy vs. T1D groups and the T1D vs. T2D groups. Unfortunately, childhood-onset T2D did not attract the attention of researchers. Hence, we still do not know the differences and similarities between healthy individuals and T2D patients. In this study, we identified the differentially expressed genes (DEGs) in the microarray data ([GSE9006](GSE9006)) of healthy group and T2D group. Then, we searched for genes closely related to T2D by performing weighted co-expression network analysis (WGCNA), which was further used to calculate the co-expression of genes. We performed functional enrichment analysis on DEGs and T2D genes. In addition, we constructed a protein-protein interaction (PPI) network for these genes to identify the ones that showed critical expression. Our research study focused on finding genes or pathways that are closely related to T2D and revealing the underlying molecular mechanisms.

Material and Methods
====================

Affymetrix microarray data
--------------------------

[@ref-20] measured and uploaded the dataset [GSE9006](GSE9006) to gene expression omnibus (GEO) (<http://www.ncbi.nlm.nih.gov/geo/>). This dataset contained the gene expression of peripheral blood mononuclear cells (PBMCs), which were obtained from 24 healthy children, 43 children with newly diagnosed T1D, and 12 children with newly diagnosed T2D. The demographic information of volunteers was mentioned in [Table 1](#table-1){ref-type="table"}. We selected data of healthy children and children with newly diagnosed T2D for further analysis. The dataset was based on the following platform: [GPL97](GPL97) \[HG-U133B\] Affymetrix Human Genome Array.
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###### The characteristics of included cases and controls.
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                               Children with T2D (*n* = 12)   Healthy control (*n* = 24)
  ---------------------------- ------------------------------ --------------------------------
  Age (year, mean ± SD)        14.0 ± 2.3                     11.3 ± 4.6
  Sex (%female)                58                             58
  Race                         2 Caucasian                    11 Caucasian
                               2 Hispanic                     7 Hispanic
                               7 African--American            6 Mixed or unknown ethnicities
                               1 Asian                        
  BMI (mean *Z* score ± SD)    2.33 ± 0.32                    Unknown
  Initial pH less than 7.3     17%                            Unknown
  Initial HbA1c (mean ± SD )   12.2 ± 1.5                     Unknown

**Notes.**

BMI, Body mass index

DEG analysis
------------

In this study, we analyzed DEGs in healthy and T2D patients by using the limma package ([@ref-36]), which is the core component of Bioconductor and is widely used to process the microarray data. \|logFC\| ≥0.5 and *P* \< 0.01 was set as the cut-off criteria.

WGCNA analysis
--------------

To determine the co-expression module and the link between the module and the phenotype, we performed WGCNA of the normalized gene expression matrix by using WGCNA package ([@ref-24]). It is important to note that WGCNA package is an effective data mining tool used to identify all kinds of modules that are highly related to a phenotype, including genes, miRNA, and LncRNA. In this study, the genes were divided into 21 modules, including 20 effective modules and one ineffective module (identified as gray module). We calculated the link between each module and co-expressed genes in healthy and T2D groups.

GO and pathway enrichment analyses
----------------------------------

Gene ontology (GO) ([@ref-3]) includes three types of data, namely, cellular components (CC), molecular functions (MF), and biological processes (BP). GO is often used to annotate genes according to a defined set of structured words. The Kyoto Encyclopedia of Genes and Genomes (KEGG) ([@ref-21]) is used to match the information of gene pathways. Reactome is a great tool to obtain gene-related pathways and interactions ([@ref-4]). GO and pathway enrichment analyses are used to help us figure out the information of genes. In this study, GO and pathway enrichment analysis was performed on DEGs and the genes highly related to T2D. *P* \< 0.05 was the criterion used for distinguishing non-meaningful pathways. At least two genes were required to enrich each pathway.

PPI network analysis
--------------------

GeneMANIA software ([@ref-30]) was used to establish gene interactions and to predict gene function. The PPI network was used to analyze DEGs and genes in both the high-associated modules. We set kappa \>0.4 and *P* \< 0.05 as the criteria. Network analysis was performed by running GeneMANIA software run in Cytoscape application. The critical hubs were the nodes that were highly connected to other nodes.

Analysis of diseases and transcription factors related to critical genes
------------------------------------------------------------------------

The Comparative toxicogenomics database (CTD) ([@ref-8]) is often used to analyze the link between genes and diseases. In this study, we determined whether the target gene was linked to diabetes. In the CTD database, we searched all the genes that were reportedly associated with T2D and T1D. Then, we matched these genes with our target genes. iRegulon ([@ref-18]) is a plugin for the Cystoscape application, which uses a set of pre-defined transcription factors (TFs) and direct transcriptional targets to extract information related to TFs in a group of co-expressing genes. Ultimately, the output is a set of transcription tracks and a list of genes associated with the tracks. A network was constructed with the output results. To reflect the reliability of results, the values of relevant parameters were set as follows: the maximum false discovery rate on motif similarity = 0.001; the minimum identity between orthologous genes = 0.05, and the normalized enrichment score (NES) = 5. Further analysis was performed on pairs for which NES ≥ 5.

Results
=======

DEG analysis
------------

We compared the gene expression levels of healthy children and children with newly diagnosed T2D. [Figure 1](#fig-1){ref-type="fig"} showed that 521 genes had differential expression, including 192 up-regulated genes and 329 down-regulated genes. The average logFC value of up-regulated genes was 0.787, while the average logFC value of down-regulated genes was −0.938. The terms with logFC \>1.5 or logFC \<--1.5 are EGR1 (logFC = 2.005), HIST1H4PS1 (logFC = 1.793), CELF4 (logFC = 1.665), CXorf56 (logFC = 1.573), PROK2 (logFC = 1.564), ORMDL3 (logFC = −2.496), [BF514098](http://www.ncbi.nlm.nih.gov/nuccore/BF514098) (logFC = −1.846), MRPL39 (logFC = −1.788), LINC00644 (logFC = −1.772), LOC90246 (logFC = -1.770), POLB (logFC = −1.729), [AA683356](http://www.ncbi.nlm.nih.gov/nuccore/AA683356) (logFC = −1.692), MIR497HG (logFC = −1.653), [AK026199](http://www.ncbi.nlm.nih.gov/nuccore/AK026199) (logFC = −1.616), [AA885523](http://www.ncbi.nlm.nih.gov/nuccore/AA885523) (logFC = −1.592), VN1R3 (logFC = −1.588), TOX2 (logFC = −1.579), [BF433815](http://www.ncbi.nlm.nih.gov/nuccore/BF433815) (logFC = −1.576), [AW629036](http://www.ncbi.nlm.nih.gov/nuccore/AW629036) (logFC = −1.555), LRRC45 (logFC = −1.546), LRCH3 (logFC = −1.533), TUG1 (logFC = −1.528), [BF110980](http://www.ncbi.nlm.nih.gov/nuccore/BF110980) (logFC = −1.517), PLD5 (logFC = −1.513) and CCDC102B (logFC = −1.504).

![Heatmaps of differentially expressed genes.\
In the right rectangle, red represents a higher expression level, while blue represents a lower expression level. The middle strip indicates the grouping information. The red section is healthy group, while the black section represents the patient group. The right and bottom labels indicate grouping information and gene symbols, respectively. The color key is a histogram. The *X* axis is a numerical value representing the level of gene expression, and the *Y* axis is the number of corresponding squares. This histogram corresponds to the squares.](peerj-07-6343-g001){#fig-1}

WGCNA analysis
--------------

Under the condition of soft threshold = 6, each gene was divided into 21 modules (20 valid modules and one invalid module) by cluster analysis; the correlation of these genes with T2D phenotype was calculated. [Figure 2](#fig-2){ref-type="fig"} shows the correlation results. It can be seen that the blue and cyan modules have a significant correlation with T2D, which are 0.74 (*p* \< 0.01) and 0.69 (*p* \< 0.01), respectively. The two modules contain a total of 636 genes; the blue module contains 539 genes, while the cyan module contains only 97 genes.

![The results of weighted co-expression gene network analysis.\
An overview of the co-expressed genes in the current study, demonstrating the relevance of gene modules and phenotypes. (A) Scale independence used in WGCNA. (B) Mean network connectivity of soft-thresholding powers used in WGCNA. A soft threshold of 6 is the most suitable value. (C) Cluster dendrogram of the identified co-expression modules. In this figure, each gene is represented as a leaf and corresponds to a color module. Each color indicates that each gene in its corresponding cluster dendrogram belongs to the same module. If some genes have similar changes in expression, then these genes may be functionally related. Moreover, all these genes can further be included into a single module. The grey block represents that the genes that do not co-express with genes of any other color module. (D) Module-trait weighted correlations and corresponding *P*-values for the identified gene module and their clinical status (healthy and children-onset T2D). The label of color on the left represents the strength of correlation, from 1 (red) to --1 (blue).](peerj-07-6343-g002){#fig-2}

GO and pathway enrichment analyses
----------------------------------

GO, Reactome, and KEGG pathway analyses were used to determine the up-regulated genes, the down-regulated genes, and the genes significantly correlated to T2D (blue and cyan). [Table 2](#table-2){ref-type="table"} displays the GO results, which indicated that the up-regulated genes were highly enriched in cytokine metabolic process, cytokine biosynthetic process, interleukin-1 beta production, positive regulation of cytokine biosynthetic process, and MyD88-dependent toll-like receptor(TLR) signaling pathway. The down-regulated expression of differential genes was mainly associated with the development of lymph vessel and fat pad. In T2D-related modules, the genes either conjugated or removed small proteins to perform functions, such as RNA binding, RNA processing, and protein modification. Some genes were further enriched in organelles' lumen, nuclear region, and other items.
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###### GO analysis of DEGs and genes in highly correlative module.
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  ID                        Description                                                    No. of genes   *P*-value
  ------------------------- -------------------------------------------------------------- -------------- -----------
  **Upregulated genes**                                                                                   
  GO-BP terms                                                                                             
  GO:0042107                cytokine metabolic process                                     6              3.02E--04
  GO:0042089                cytokine biosynthetic process                                  6              2.76E--04
  GO:0032611                interleukin-1 beta production                                  5              2.53E--04
  GO:0042108                positive regulation of cytokine biosynthetic process           5              1.47E--04
  GO:0002755                MyD88-dependent toll-like receptor signaling pathway           5              8.59E--06
  GO:0032732                positive regulation of interleukin-1 production                4              4.47E--04
  GO:0045351                type I interferon biosynthetic process                         4              2.19E--06
  GO:0032728                positive regulation of interferon-beta production              4              9.85E--05
  GO:0032731                positive regulation of interleukin-1 beta production           4              2.39E--04
  GO:0050702                interleukin-1 beta secretion                                   4              4.85E--04
  GO:0006491                N-glycan processing                                            3              3.84E--04
  GO:0034755                iron ion transmembrane transport                               3              4.49E--04
  GO:0042228                interleukin-8 biosynthetic process                             3              1.84E--04
  GO:0045414                regulation of interleukin-8 biosynthetic process               3              1.48E--04
  GO:0045350                interferon-beta biosynthetic process                           3              3.52E--05
  GO:0045357                regulation of interferon-beta biosynthetic process             3              3.52E--05
  GO:0045416                positive regulation of interleukin-8 biosynthetic process      3              5.00E--05
  GO:0045359                positive regulation of interferon-beta biosynthetic process    3              1.48E--05
  GO:0045356                positive regulation of interferon-alpha biosynthetic process   2              3.43E--04
  **Downregulated genes**                                                                                 
  GO-BP terms                                                                                             
  GO:0001945                lymph vessel development                                       4              1.81E--04
  GO:0060613                fat pad development                                            3              2.62E--05
  Blue-Cyan module                                                                                        
  GO-BP terms                                                                                             
  GO:0070647                protein modification by small protein conjugation or removal   59.00          2.74E--05
  GO:0032446                protein modification by small protein conjugation              51.00          2.49E--05
  GO:0006396                RNA processing                                                 51.00          5.13E--05
  GO:0006397                mRNA processing                                                35.00          2.44E--06
  GO:0008380                RNA splicing                                                   29.00          7.10E--05
  GO:0007034                vacuolar transport                                             13.00          5.86E--05
  GO:0007041                lysosomal transport                                            11.00          1.04E--04
  GO:0007029                endoplasmic reticulum organization                             8.00           3.32E--05
  GO:0071786                endoplasmic reticulum tubular network organization             5.00           9.27E--05
  GO-CC terms                                                                                             
  GO:0043233                organelle lumen                                                216.00         1.49E--09
  GO:0070013                intracellular organelle lumen                                  216.00         1.49E--09
  GO:0044428                nuclear part                                                   203.00         4.75E--13
  GO:0031981                nuclear lumen                                                  189.00         1.36E--12
  GO:0005654                nucleoplasm                                                    164.00         1.55E--11
  GO:0044451                nucleoplasm part                                               60.00          5.83E--06
  GO-MF terms                                                                                             
  GO:0003723                RNA binding                                                    79.00          1.65E--05
  GO:0019787                ubiquitin-like protein transferase activity                    31.00          2.04E--05
  GO:0004842                ubiquitin-protein transferase activity                         30.00          2.01E--05

**Notes.**

GOgene ontologyDEGsdifferentially expressed genesBPbiological processCCcellular componentMFmolecular functioncGMPcyclic guanosine monophosphate

[Table 3](#table-3){ref-type="table"} presents the results of KEGG and Reactome pathway analysis, indicating the involvement of up-regulated genes in TLR signaling pathway and in diseases of the immune system. In T2D-related modules, the genes were mainly involved in vasopressin-regulated water reabsorption pathways. The down-regulated expression of differential genes was mainly enriched through chromatin-modifying enzymes, chromatin organization, and mRNA splicing.
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###### KEGG and Reactome pathway enrichment analyses of DEGs and genes in highly correlative module.
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  ID                    Description                                                 No. of genes   *P*-value
  --------------------- ----------------------------------------------------------- -------------- -----------
  Upregulated genes                                                                                
  KEGG                                                                                             
  KEGG:04620            Toll-like receptor signaling pathway                        5              1.16E--03
  Reactome Pathways                                                                                
  R-HSA:168898          Toll-Like Receptors Cascades                                6              1.31E--03
  R-HSA:8876198         RAB GEFs exchange GTP for GDP on RABs                       5              6.00E--04
  R-HSA:5260271         Diseases of Immune System                                   3              1.09E--03
  R-HSA:5602358         Diseases associated with the TLR signaling cascade          3              1.09E--03
  Downregulated genes                                                                              
  Reactome Pathways                                                                                
  R-HSA:3247509         Chromatin modifying enzymes                                 10             3.10E--04
  R-HSA:4839726         Chromatin organization                                      10             3.10E--04
  R-HSA:72163           mRNA Splicing---Major Pathway                               8              3.76E--04
  R-HSA:72172           mRNA Splicing                                               8              5.00E--04
  Blue-Cyan module                                                                                 
  KEGG                                                                                             
  KEGG:04962            Vasopressin-regulated water Reabsorption                    3              1.12E--03
  Reactome Pathways                                                                                
  R-HSA:909733          Interferon alpha/beta signaling                             3              4.08E--03
  R-HSA:8852135         Protein ubiquitination                                      3              5.55E--03
  R-HSA:8866652         Synthesis of active ubiquitin: roles of E1 and E2 enzymes   3              3.60E--04
  R-HSA:983152          Transfer of ubiquitin from E1 to E2                         3              1.05E--03
  R-HSA:193648          NRAGE signals death through JNK                             2              3.10E--02
  R-HSA:933528          Interaction of MEKK1 with TRAF6                             2              5.91E--04
  R-HSA:933530          Activation of IKK by MEKK1                                  2              1.15E--03

**Notes.**

KEGGThe Kyoto Encyclopedia of Genes and GenomesDEGsdifferentially expressed genes

PPI network analysis
--------------------

We performed PPI network analysis on 112 genes, which were present in both the DEGs and the highly correlated modules. As shown in [Fig. 3](#fig-3){ref-type="fig"}, we obtained 92 nodes and 254 pairs by setting the PPI score \>0.4. An intersection was observed in genes of following types: the genes with logFC \>0.6 or logFC \<--0.6 in the DEGs, the genes with greater than average degree in the high correlation module, and the genes with greater than average degree in the PPI network. A total of 10 genes were obtained, all of which were up-regulated. The details were presented in [Table 4](#table-4){ref-type="table"}. The 11 genes with the higher degree in the network are C14orf119 (logFC = 16), NAMPT (logFC = 15), NRBF2 (logFC = 14), MTO1 (logFC = 14), PIK3CG (logFC = 13), RNF146 (logFC = 13), VPS50 (logFC = 13), CHM (logFC = 12), GPD2 (logFC = 12), RAB10 (logFC = 12) and ATAD1 (logFC = 12), which have the significant influence on the whole network.

![Protein--protein interaction network.\
The results of PPI analysis of DEGs in the highly correlated module. Gray lines, purple lines, red lines, and blue lines represent co-expression, co-localization, physical interactions, and shared protein domains, respectively. The link weight is marked with lines of different thicknesses.](peerj-07-6343-g003){#fig-3}
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###### Information of critical genes.
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  Gene symbol   WGCNA module   logFC         WGCNA degree (*n*)   PPI degree (*n*)
  ------------- -------------- ------------- -------------------- ------------------
  TRAPPC11      blue           1.292140612   193                  8
  CHM           blue           0.801222752   138                  12
  C14orf119     blue           0.777600335   262                  16
  ETNK1         blue           0.744750579   161                  11
  GSKIP         blue           0.697264964   317                  11
  PIK3CG        blue           0.688131993   178                  13
  ZNF420        blue           0.656561519   96                   7
  QSER1         blue           0.653280142   126                  10
  RAB10         blue           0.639129192   115                  12
  MRPL35        blue           0.638260852   240                  7

**Notes.**

WGCNAweighted co-expression network analysislogFClog~2~ fold changePPIprotein--protein interaction networkdegreethe number of related genes in a given analysis

Analysis of the transcription factors of maker genes
----------------------------------------------------

A total of 12 genes were used for further analysis. Among them, 10 important genes were obtained from PPI analysis. The remaining two genes were DEGs with large values of logFC, namely, EGR1 (logFC = 2.00) and NAMPT (logFC = 1.32). In the CTD database, these 12 genes are reportedly linked with T2D. In addition, we analyzed and compared their reports in T1D group. The results were shown in [Table 5](#table-5){ref-type="table"}.
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###### No. of references of genes in T2D or T1D.
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  Gene        T2D(n)   T1D(n)
  ----------- -------- --------
  EGR1        104      14
  NAMPT       99       26
  MRPL35      27       2
  QSER1       25       1
  ETNK1       11       2
  RAB10       9        5
  CHM         6        2
  PIK3CG      6        6
  TRAPPC11    4        2
  C14orf119   4        1
  GSKIP       1        2
  ZNF420      1        1

**Notes.**

The number of references related of T2D or T1D is given by the comparative toxicogenomics database.

T1Dtype 1 diabetesT2Dtype 2 diabetes

As shown in [Fig. 4](#fig-4){ref-type="fig"}, we analyzed the transcription factor regulatory network of these genes. We found that NES ≥ 5 was for the following transcription factors: DEAF1 (NES = 7.114, degree = 6), GMEB2 (NES = 6.595, degree = 4), MAF1 (NES = 5.641, degree = 3), NKX3-2 (NES = 5.287, degree = 3), WDR83 (NES = 5.041, degree = 4).

![The analysis of transcription factor regulatory network.\
The pink and green nodes represent the important genes identified by previous analysis and the transcription factors that have regulatory relationships, respectively. Some important genes were not pictured in the network because they were single node, which means that no transcription factor linked to them. The different colored arrows indicate the genes regulated by different transcription factors, making the results easier to observe.](peerj-07-6343-g004){#fig-4}

Discussion
==========

In humans, early growth response 1 (EGR1) is a protein-coding gene. Previous studies have reported that glucagon can transiently activate EGR1 in liver cells. To mediate glucagon-regulated gluconeogenesis, hepatocytes up-regulate the expression of gluconeogenic genes. By blocking the function of EGR1 gene, we could increase glycogen content in hepatic cells, which would improve the tolerance toward pyruvate and lower fasting blood glucose. The gene EGR1 enhances insulin resistance in T2D patients with chronic hyperinsulinemia. Insulin resistance is one of the most significant causes of T2D ([@ref-39]). The gene EGR1 promotes the development of gestational diabetes by adversely impacting the glucagon-controlled gluconeogenesis ([@ref-47]). In addition, EGR1 promotes also diabetic nephropathy, which is one of the most common complications of diabetes ([@ref-43]). Several findings have indicated that EGR1 promotes the inflammation within muscle and adipose ([@ref-9]) and also acts as an inflammatory mediator in reproductive tissues ([@ref-41]). Indeed, the expression of EGR1 gene was unregulated in the placenta of obese women. A previous study has shown that the up-regulated expression of IL-8, IL-6, and TNFα was induced by EGR1 gene in BeWo cells ([@ref-37]). These findings indicated that EGR1 contributed to placental inflammation in obese women. Maternal adiposity must have triggered the expression of EGR1 in umbilical cord tissue ([@ref-41]). Current research and previous studies have proved that EGR1 gene has significantly affected many aspects of diabetes and obesity. In multiple tissues of T2D patients, statistically significant differences were found in the expression of EGR1 gene.

Nicotinamide phosphoribosyltransferase (NAMPT) is a protein-coding gene in humans. Previous studies have reported that NAMPT is an adipocytokine that exhibits pro-inflammatory and immunoregulatory properties ([@ref-31]) and regulates beta-cell insulin secretion ([@ref-35]). Furthermore, NAMPT is involved in insulin resistance and chronic inflammation, which promotes the development of T2D ([@ref-28]; [@ref-16]; [@ref-32]). Obesity is an important factor that leads to the development of diabetes. In obese and overweight patients with metabolic syndrome, the expression of NAMPT increases in the plasma ([@ref-10]) and simulates the effect of insulin ([@ref-11]). However, a previous study has reported that NAMPT is related to only T2D and not obesity ([@ref-25]). Some studies have reported plasma levels of visfatin, the product of NAMPT, increases in obese people ([@ref-17]), indicating that further research must be conducted to determine the relationship between NAMPT and obesity. Interestingly, the expression of NAMPT was found to be significantly higher in patients with gestational diabetes. This indicates that NAMPT is involved in the molecular mechanism of gestational diabetes ([@ref-23]). Several studies have reported that Young women with gestational diabetes usually give birth to an overweight baby. This phenomenon has been attributed to intrauterine growth, which increases the prevalence of T2D in the offspring ([@ref-38]). Because NAMPT is also conspicuously up-regulated in children with T2D, it is necessary to further study the genetic mechanism of NAMPT in gestational diabetes patients and their offspring. These findings suggest that NAMPT is a marker gene in patients with childhood-onset T2D.

In this study, we also found that chronic inflammation was somewhat related to childhood-onset T2D. Thus, childhood-onset T2D might be caused by multiple risk factors. For the treatment and prevention of childhood-onset T2D, we need to correctly identify the contribution and sequence of risk factors. Hence, further studies must be conducted to confirm whether gestational diabetes and chronic inflammation are closely related to childhood-onset T2D.

According to KEGG, up-regulated genes are mainly enriched in the signaling pathways of TLR. The enrichment results of Reactome pathways indicated that up-regulated genes were related to the TLR Cascades, suggesting that TLRs play a pivotal role in childhood-onset T2D. Reactive oxygen is produced excessively in obese people, which leads to an imbalance in the endogenous antioxidant capacity and causes oxidative stress in adipocytes ([@ref-13]). Obesity also promotes the excessive production of pro-inflammatory adipokines, which further aggravate the chronic inflammation of adipocytes ([@ref-34]). In fact, several studies have explained the association between obesity and chronic inflammation. These studies have further reported that chronic inflammation causes insulin resistance in obese people. Insulin resistance is a precursor to T2D in adults. These studies mainly investigated the adipose tissue of adults. In this study, we found that TLR signaling pathways mainly enriched up-regulated genes in PBMCs. In fact, TLR2 and TLR4 are important cell membrane receptors that elicit innate immune responses to infection ([@ref-40]; [@ref-7]; [@ref-2]). Previous studies have shown that TLR2/4 and JNK signaling pathways play a pivotal role in activating CD11c (+) myeloid proinflammatory cells, which further promotes inflammation and subsequent insulin resistance in cells ([@ref-33]). The TLR4 signaling pathway participates in JNK activation and instigates palmitate-induced apoptosis of INS-1β cells. With the knockout of TLR4, we blocked palmitate-induced apoptosis of INS-1 cells; however, no such phenomenon was observed with the knockdown of TLR2 ([@ref-26]). The inflammatory factors produced during immunization play an important role in obesity-related T2D ([@ref-14]). Some immune-related diseases are complications of diabetes. For example, some diabetic patients may develop a chronic airway inflammation, which further causes asthma. The above results indicate that children may develop chronic inflammation, which further induces insulin resistance and promotes the development of T2D. In addition, we also found that several other genes, such as PIK3CG, ZNF420 were also functionally related to inflammation and immune response ([@ref-12]; [@ref-42]). Therefore, this result further validates our findings.

In previous studies, animal models or elderly patients were investigated to elucidate the mechanism of T2D. Ours is the first study to partially elucidate the molecular mechanism of childhood-onset T2D with the help of bioinformatics. We found the marker genes (EGR1, NAMPT) and TLR signaling pathways of childhood-onset T2D. The up-regulated expression of EGR1 and NAMPT in PBMCs seems to be a gene marker of childhood-onset T2D. The results were compared with the gene expression of middle-aged and older patients with T2D. Thus, there is a genetic mechanism of NAMPT in gestational diabetes patients and their offspring. Such an offspring will have an increased risk of developing childhood-onset T2D. Children are less affected by environmental factors than adults, which allows us to speculate that genetic factors have more influence on childhood-onset T2D. Our findings suggest that NAMPT may be the key to understanding this issue. In addition, TLRs are important proteins involved in non-specific immunity and are a bridge linking specific and non-specific immunity. TLR4 recognizes not only foreign pathogens, but also endogenous substances and degradants. Given the differences in the immune system between children and adults, as well as the special circumstances in which the fetus grows in the uterus, we believe that in children with T2D, the factors that activate the TLR signaling pathway cannot be equated with those of adults. The above results only analyze the underlying mechanisms of EGR1 and NAMPT in children with T2D. We present more details as well, including genes with higher logFC and specific logFC values, genes with higher degrees and associated values, and information on transcription factors, which provide ideas for subsequent research on childhood-onset T2D. It must be emphasized that the physical condition of a child is very different from that of an adult. Therefore, future research studies must focus on elucidating the mechanisms of occurrence, prevention strategies, and treatment of children and adolescents with T2D.

Conclusion
==========

EGR1 and NAMPT can be used as marker genes for childhood-onset T2D, and gestational diabetes and chronic inflammation are risk factors that lead to the development of childhood-onset T2D.
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